Protalix BioTherapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2014 | 93.6M |
| FY2015 | 99.8M |
| FY2016 | 124.1M |
| FY2017 | 143.7M |
| FY2018 | 14.8M |
| FY2019 | 14.8M |
| FY2020 | 29.1M |
| FY2021 | 44.1M |
| FY2022 | 48.5M |
| FY2023 | 82.4M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2014 | 93.6M |
| FY2015 | 99.8M |
| FY2016 | 124.1M |
| FY2017 | 143.7M |
| FY2018 | 14.8M |
| FY2019 | 14.8M |
| FY2020 | 29.1M |
| FY2021 | 44.1M |
| FY2022 | 48.5M |
| FY2023 | 82.4M |